• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Viking Therapeutics, Inc. - Common Stock (NQ:VKTX)

24.77 -1.07 (-4.14%)
Official Closing Price Updated: 4:15 PM EST, Nov 20, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,653,956
Open 25.62
Bid (Size) 25.00 (300)
Ask (Size) 25.35 (10,000)
Prev. Close 25.84
Today's Range 24.67 - 26.50
52wk Range 23.82 - 43.10
Shares Outstanding 99,581,693
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Viking Therapeutics Eyes 2029 Obesity Drug Launch, Tests Less-Frequent Dosing ↗
November 18, 2026
Viking Therapeutics (NASDAQ:VKTX) is preparing for a potential 2029 launch of its obesity drug candidate VK2735 while studying whether patients can maintain weight loss with less frequent injections or... 
Via MarketBeat
News headline image
Have $1,000? This Beaten-Down Biotech Has 4 Phase 3 Obesity Trials Underway. ↗
November 18, 2026
Even a small share of the massive market for weight loss drugs could lead to a significant increase in this company's share price. 
Via The Motley Fool

Performance

52-Week Range 42.5% below 52-week high
24.77
23.8252W Low 43.1052W High
1 Week 13.3% below 1-week high
24.671W Low 28.581W High

Viking Therapeutics, Inc. - Common Stock (VKTX) traded between $23.82 and $43.10 over the past 52 weeks and last traded at $24.77, 42.5% below its 52-week high. Over the past week it ranged between $24.67 and $28.58.

Past 12 Months
-7.6%
-6.1%
-26.9%
-19.8%
-30.1%
-27.7%
1W -$2.03
1M -$1.61
3M -$9.12
6M -$6.12
YTD -$10.65
1Y -$9.50

VKTX was -27.7% over the past year, -19.8% over six months, -30.1% year to date, -7.6% in the last week.

12 Months vs Market
VKTX
-27.7%
DIA
+5.0%
SPY
+5.7%
QQQ
+3.9%
IWM
+12.0%

Over the past 12 months VKTX returned -27.7% versus DIA (Dow) +5.0%, SPY (S&P 500) +5.7%, QQQ (Nasdaq 100) +3.9% and IWM (Russell 2000) +12.0%.

Volume & Liquidity 0.70× 3-mo avg
Today 3,653,956 3-mo avg 5.2M
1W
3.5M
1M
4.0M
3M
5.2M
6M
3.8M
YTD
3.3M
1Y
3.2M

VKTX most recently traded 3,653,956 shares against a 3-month average daily volume of 5.2M.

More News

Read More
News headline image
Prediction: $10,000 Invested in Viking Therapeutics Before Its Oral Phase 3 Readouts Could Be Worth This Much by 2028 ↗
November 13, 2026
Via The Motley Fool
Viking Therapeutics (NASDAQ:VKTX) Q3 2026 Earnings: Wider Loss as Obesity Pipeline Advances ↗
October 28, 2026
Via Chartmill
News headline image
Eli Lilly Just Raised Its 2026 Sales Forecast to as Much as $92 Billion. But Is Viking Therapeutics the Next Big Obesity Winner? ↗
November 11, 2026
Via The Motley Fool
News headline image
Here's the 1 Stock I'd Most Want to Buy If the Market Crashes ↗
November 05, 2026
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
Viking Therapeutics Trades 23% Below Its Own $35 Secondary Offering Price. Here's Why That Could Be a Gift for Patient Investors. ↗
November 04, 2026
Via The Motley Fool
News headline image
How I'd Invest $10,000 Right Now ↗
November 04, 2026
Via The Motley Fool
Topics ETFs Stocks
News headline image
Peptide Therapies Are Changing the Future of Medicine — And the Market Could Reach $335 Billion
November 03, 2026
From FN Media
Via GlobeNewswire
News headline image
Peptide Therapies Are Changing the Future of Medicine — And the Market Could Reach $335 Billion
November 03, 2026
Via FinancialNewsMedia
News headline image
UBS Just Initiated Coverage of Viking Therapeutics With a Buy Rating and a $94 Target. Here's the Bull Case. ↗
November 02, 2026
Via The Motley Fool
News headline image
Viking Therapeutics Q3 Earnings Call Highlights ↗
October 29, 2026
Via MarketBeat
Topics Earnings
News headline image
Viking (VKTX) Q3 2026 Earnings Call Transcript ↗
October 29, 2026
Via The Motley Fool
Topics Earnings
News headline image
Prediction: $1,000 Invested in Viking Therapeutics Today Will Be Worth This Much in 5 Years ↗
October 20, 2026
Via The Motley Fool
News headline image
Viking Therapeutics Initiates Pivotal Phase 3 Trial: Here's Why Investors Have Reason for Optimism After a Disappointing Phase 2 ↗
October 20, 2026
Via The Motley Fool
News headline image
Viking Therapeutics Just Raised $575 Million. Here's What It Means for the Obesity Stock's Next Chapter. ↗
October 18, 2026
Via The Motley Fool
News headline image
4 High-Risk Stocks Built for Big Returns ↗
October 14, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
3 Absurdly Cheap Stocks to Buy Before the End of 2026 ↗
October 13, 2026
Via The Motley Fool
News headline image
Oppenheimer Thinks Viking Therapeutics Stock Can Soar to $120. Here's the Math Behind the Ultra-Bullish Call. ↗
October 12, 2026
Via The Motley Fool
News headline image
2 Stocks That Could Soar in Q4 ↗
October 12, 2026
Via The Motley Fool
News headline image
Viking Therapeutics' Oral Obesity Drug Advances to Phase 3 Testing. Is Now the Time to Buy This Biotech Stock? ↗
October 10, 2026
Via The Motley Fool
News headline image
Here Are My Top 4 Stocks to Buy in October ↗
October 05, 2026
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Should You Buy Viking Therapeutics Stock While It Trades Below Its $35 Offering Price? ↗
October 02, 2026
Via The Motley Fool
News headline image
Prediction: This Stock Could Double Over the Next 5 Years ↗
October 02, 2026
Via The Motley Fool
News headline image
Novo Is Open to Acquisitions. Here Are 2 Companies That Would Be Great Candidates to Buy ↗
September 30, 2026
Via The Motley Fool
Topics Initial Public Offering

Frequently Asked Questions

Is Viking Therapeutics, Inc. - Common Stock publicly traded?
Yes, Viking Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Viking Therapeutics, Inc. - Common Stock trade on?
Viking Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Viking Therapeutics, Inc. - Common Stock?
The ticker symbol for Viking Therapeutics, Inc. - Common Stock is VKTX on the Nasdaq Stock Market
What is the current price of Viking Therapeutics, Inc. - Common Stock?
The current price of Viking Therapeutics, Inc. - Common Stock is 24.77
When was Viking Therapeutics, Inc. - Common Stock last traded?
The last trade of Viking Therapeutics, Inc. - Common Stock was at 11/20/26 04:15 PM ET
What is the market capitalization of Viking Therapeutics, Inc. - Common Stock?
The market capitalization of Viking Therapeutics, Inc. - Common Stock is 2.47B
How many shares of Viking Therapeutics, Inc. - Common Stock are outstanding?
Viking Therapeutics, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap